H_1受体阻滞剂在特发性肺间质纤维化所致呼吸衰竭中的应用探讨被引量：4

The Disscussion of H_1 Recepter Blokers' s Effect in Failure of Respiration Induced by Idiopathic Pulmonary Fibrosis

下载PDF

导出

摘要目的:观察H1受体阻滞剂治疗特发性肺间质纤维化所致的呼吸衰竭患者的疗效。方法:总结本院2011年1月-2012年5月60例弥漫性肺间质纤维化合并Ⅰ型呼吸衰竭患者,按照随机数字表法分为对照组和观察组30例,对照组予以抗感染,改善通气,平喘等治疗;观察组在上述治疗的基础上予以H1受体阻滞剂(非那根片)治疗,对比观察两组患者呼吸频率,心率、动脉血气分析、肺功能变化情况。结果:观察组在应用H1受体阻滞剂后呼吸频率、心率、SpO2、动脉血气分析、DLCO%pre(一氧化碳弥散量占预计值百分比)、患者自我喘息症状缓解程度改善方面均明显优于对照组,比较差异有统计学意义(P<0.05)。结论:H1受体阻滞剂能缓解呼吸衰竭所引起的症状,减少氧耗,改善血气水平。 Objective：To investigate the effect of H1 recepter blokers in failure of respiration induced by idiopathic pulmonary fibrosis（IPF）. Method：Sixty patients with IPF were randomly divided into the control group and the observation group,with 30 patients in each group.Patients in the control group were given antibiotic,treatments on dysfunction of ventilation.Patients in the observation group were given H1 recepter blocker（Phenergan）, besides the same treatment of the control group.The clinical effects of the two groups were compared after 2 weeks after treatment.Result：The clinical symptoms and improvement in pulmonary diffusion of the observation group were better than those in the control group,such as breathing rate,heart rate, SpO2,arterial blood gas analysis,DLCO%pre,and the difference between the two groups were all statistically significant（P〈0.05）.Conclusion：The effect of H1 recepter blocker on IPF can relieve the symptoms of respiratory failure caused by,reduce the oxygen consumption,and improve the blood gas levels.

作者张凯

机构地区三峡大学附属仁和医院

出处《中国医学创新》 CAS 2014年第3期25-27,共3页 Medical Innovation of China

关键词特发性肺间质纤维化呼吸衰竭 H1受体拮抗剂非那根 Idiopathic pulmonary fibrosis Failure of respiration H1 recepter blokers Phenergan

分类号 R563.8 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献10

1Raghu G, Collard H, Egan J J, et al.An official ATS,rERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J].Am Jrespir Crit Care Med, 2011, 183 ( 2 ) : 788-824.
2Navaratnam V, Fleming K M, West J, et al.The rising incidence of idiopathic pulmonary fibrosis in the UK[J].Thorax, 2011, 66 (2) : 462-467.
3Bhah N, Baran C P, Allen J, et al.Promising phaermacologic innovation in treating pulmonary fibrosis[J].Respiration, 2004, 71( 6 ): 656-657.
4Yamaki K, Thorlacius H, Xie X, et al.Charaacteristics of histamine- induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery[J].Br J Pharmacol, 1998, 123 ( 3 ) : 390.
5Benbarek H, Mouithys-Mickalad A, Deby-Dupont G, et al.High con centrations of histamine stimulate equine polymprphonuclear neutmphils to produce reactive oxygen[J].Species Res, 1999, 48 ( 11 ) : 594.
6Kroegel C, Mock B, Hengst U, et al.Interferon-gamma-lb, therapeutic option in avanced idiopathic pulmonary fibrosis[J]. Respiration, 2004, 71 (6) : 656-657.
7Shimizu T, Nishihira J, Watanabe H, et al. Cetirizine, an Hi-receptor antagonist inhibitory factor: its potenial anti-inflammatory action[J]. Clin Exp Allergy, 2004, 34 ( 1 ) : 103.
8谢建丰,陈伟,何振华.特发性肺纤维化治疗进展[J].中国现代医药杂志,2012,14(10):124-127. 被引量：5
9覃珍,陈超.H_1受体阻滞剂应用的研究进展[J].陕西医学杂志,2005,34(4):473-475. 被引量：9
10崔嗣庚.精神因素诱发哮喘5例[J].中华医学写作杂志,2003,10(19):1760-1761. 被引量：1

二级参考文献41

1Yamaki K, Thorlacius H, Xie X,et al.Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol, 1998; 123 (3) : 390.
2Yamashiro K, Kiryu J, Tsujikawa A, et al.Suppressive effects of histamine H1 receptor antagonist diphenhydramine on the leukocyte infiltration during endotoxin-induced uveitis. Exp Eye Res,2001;73(1) : 69.
3Benbarek H, Mouithys-Mickalad A, Deby-Dupont G,et al. High concentrations of histamine stimulate equine polymorphonuclear neutrophils to produce reactive oxygen species. Inflamm Res, 1999; 48(11) : 594.
4Shimizu T, Nishihira J, Watanabe H, et al.Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: its potential anti-inflammatory action . Clin Exp Allergy, 2004;34(1) : 103.
5Cook EB, Stahl JL, Barney NP, et al. Olopatadine inhibits TNFalpha release from human conjunctival mast cells. Ann Allergy Asthma Immunol, 2000;84(5) : 504.
6Benlounes N, Dupont C, Candalh C, et al. Effect of terfenadine on TNF alpha release from peripheral blood mononuclear cells during cow's milk allergy.Clin Exp Allergy,1997;27(8): 942.
7Bakker RA, Schoonus SB, Smit M J, et al. Histamine H1-receptor activation of nuclear factor-kappa B:roles for G beta gamma- and G alpha (q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol, 2001;60(5) : 1133.
8Miki I, Kusano A, Ohta S, et al. Histamine enhanced the TNF-alpha-induced expression of Eselectin and ICAM-1 on vascular endothelial cells.Cell Immunol, 1996;171(2) : 285.
9Nori M. Ebastine inhib its T cell migration,production of Th2-type cytokines and proinflammatory cytokines. ClinExpAllergy, 2003;33(11) : 1476.
10Arnold R. Cetirizine counter-regulates interleukin-8release from human epithelial cells (A549) . Clin Exp Allergy, 1999;29(12) : 1681.